Physician
Pulmonology
Gary Richmond is an expert in the field of Pulmonology. He went to New York Medical College. He over the years received 10 awards: "Top Doctors:South Florida", "Meaningful Use Stage 1 Certification", "Super Doctor", "Fellow (FACP)", "Physicians Recognition Award", "Most Valuable Physician Award", "Zoology Departmental Honors", "Phi Kappa Phi Honor Society", "Phi Beta Kappa Honor Society" and "Lifetime Service Award". Gary Richmond is also a published doctor. He has 14 paper published. The most recent paper is: Simplified maintenance therapy with abacavir/lamivudine and atazanavir after discontinuation of ritonavir. He is registered with Medicare and accepts Medicare payments.
Publications
- Simplified maintenance therapy with abacavir/lamivudine and atazanavir after discontinuation of ritonavir.
- Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation.
- Once-daily abacavir/lamivudine and ritonavir-boosted atazanavir for the treatment of HIV-1 Infection in antiretroviral-naïve patients: a 48-week pilot study.
- Safety, pharmacokinetics, and antiviral activity of HGS004, a novel fully Human IgG4 monoclonal antibody against CCR5, in HIV-1-infected patients.
- Enfuvirtide does not require dose adjustment in patients with Chronic kidney failure: results of a pharmacokinetic study of enfuvirtide in HIV-1-infected patients with...
- Metabolic effects of a growth hormone-releasing factor in patients with HIV.
- Recombinant Human growth hormone to treat HIV-associated adipose redistribution syndrome: 12 week induction and 24-week maintenance therapy.
- Pharmacokinetics, pharmacodynamics and safety of once-daily versus twice-daily dosing with enfuvirtide in HIV-infected subjects.
- A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse tr...
- Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients.
- Pharmacodynamic effects of zidovudine 600 mg once/day versus 300 mg twice/day in therapy-naïve patients infected with Human immunodeficiency virus.
- T-1249 retains potent antiretroviral activity in patients who had experienced virological Failure while on an enfuvirtide-containing treatment regimen.
- Atrial septal rupture, flail tricuspid valve, and complete Heart block due to nonpenetrating chest trauma.
Schools
New York Medical College
Beth Israel Med Center
Beth Israel Medical Center
University Of California San Francisco
University Of Massachusetts
Procedures Preformed
- Bronchoscopy
- Fiberoptic Bronchoscopy
- Pulmonary Function Tests
- Thoracentesis
- View All
Conditions Treated
- Acidosis
- Alkalosis
- Asthma
- Atelectasis
- View All
Doctors Specialties
- Internal Medicine
- Pulmonology
Accepted Insurances
Awards
- Top Doctors:South Florida
- Meaningful Use Stage 1 Certification
- Super Doctor
- Fellow (FACP)
- Physician’s Recognition Award
- Most Valuable Physician Award
- Zoology Departmental Honors
- Phi Kappa Phi Honor Society
- Phi Beta Kappa Honor Society
- Lifetime Service Award
Education
-
Mount Sinai Beth Israel
-
New York Medical College
Drug Facts
| NPI NUMBER |
|
1255345963 |
| NPPES Provider LastName |
|
RICHMOND |
| NPPES Provider FirstName |
|
GARY |
| NPPES Provider ZIPCode |
|
333161929 |
| NPPES Provider State |
|
FL |
| Specialty Description |
|
Internal Medicine |
| Total Claim Count |
|
10204.0 |
| Distinct Opioid Count |
|
2.0 |
| Opioid Claim Count |
|
53.0 |
| Percent Opioid Claims |
|
0.52 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1255345963 |
| Last Name Of The Provider |
RICHMOND |
| First Name Of The Provider |
GARY |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.